Aurora Cannabis (ACB) Total Liabilities (2018 - 2026)
Aurora Cannabis (ACB) posted quarterly Total Liabilities of $65.1 million for Q1 2026, down 61.74% year-on-year from $170.1 million in Q1 2025, and down 56.25% on a QoQ basis from $148.8 million in Q4 2025.
Aurora Cannabis (ACB) Total Liabilities (2018 - 2026) Analysis & Trends
Aurora Cannabis (ACB) has reported Total Liabilities for 9 consecutive years, with $65.1 million the latest figure, recorded in Q1 2026.
- Quarterly Total Liabilities fell 61.74% year-over-year to $65.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $65.1 million (down 61.74% YoY) and the FY2026 annual result came in at $64.6 million, down 63.22% from the prior year.
- Total Liabilities declined to $65.1 million in Q1 2026 per ACB's latest filing, from $148.8 million in the prior quarter.
- Over the last five years, Total Liabilities for ACB reached as high as $441.2 million in Q3 2022 and fell as low as $65.1 million in Q1 2026.
- A 5-year average of $216.6 million and a median of $180.9 million in 2024 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2025 — Total Liabilities increased 4.06% — and 2026, when it plunged 61.74%.
- Year by year, Total Liabilities stood at $315.9 million in 2022, then sank by 39.79% to $190.2 million in 2023, then retreated by 4.37% to $181.9 million in 2024, then retreated by 18.22% to $148.8 million in 2025, then plunged by 56.25% to $65.1 million in 2026.
- According to Business Quant data, Total Liabilities over the past three periods registered $65.1 million, $148.8 million, and $137.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 21.48 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 31.81 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 11.92 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 51.53 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 813.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 13.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 22.18 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1.50 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 6.72 Bn |
| 10 | Aurora Cannabis | 1.11 Bn | 1.03 Bn | 21.72 Mn | 65.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 65.09 Mn |
| Dec 31, 2025 | 148.77 Mn |
| Sep 30, 2025 | 137.89 Mn |
| Jun 30, 2025 | 179.82 Mn |
| Mar 31, 2025 | 170.10 Mn |
| Dec 31, 2024 | 181.92 Mn |
| Sep 30, 2024 | 165.52 Mn |
| Jun 30, 2024 | 172.80 Mn |
| Mar 31, 2024 | 175.73 Mn |
| Dec 31, 2023 | 190.23 Mn |
| Sep 30, 2023 | 200.90 Mn |
| Jun 30, 2023 | 241.39 Mn |
| Mar 31, 2023 | 299.29 Mn |
| Dec 31, 2022 | 315.94 Mn |
| Sep 30, 2022 | 441.21 Mn |
| Mar 31, 2022 | 379.08 Mn |
| Dec 31, 2021 | 421.05 Mn |
| Sep 30, 2021 | 425.28 Mn |
| Jun 30, 2021 | 203,381.79 |
| Mar 31, 2021 | 519.31 Mn |